Literature DB >> 8398990

Divergent regulation of cell surface protease expression in HL-60 cells differentiated into macrophages with granulocyte macrophage colony stimulating factor or neutrophils with retinoic acid.

A Laouar1, J Wietzerbin, B Bauvois.   

Abstract

Taking advantage of the recently demonstrated presence of N-aminopeptidases and the serine protease dipeptidyl aminopeptidase IV (DPP IV) at the surface of human myeloblastic HL-60 cells, the regulation of these protease activities in HL-60 cell differentiation has been assessed using combined spectrophotometric and flow cytometric assays. Addition of human recombinant granulocyte macrophage colony stimulating factor (rHu-GM-CSF) to HL-60 cells to induce differentiation into macrophages led to a time- and dose-dependent increase in both cell surface N-aminopeptidase and DPP IV activities. Protease up-regulation was due to an enhancement in cell surface protease number, associated with a slight rise in apparent affinities of the enzymes for their substrates. In contrast, in HL-60 cells induced to differentiate into neutrophils in the presence of retinoic acid, expression of cell surface N-aminopeptidases was almost completely abolished in a time- and dose-dependent fashion, and this down-regulation was accompanied by a weak but significant decrease in affinity. However, no noticeable difference was seen in serine DPP IV expression between retinoic acid-treated and untreated HL-60 cells. Retinoic acid treatment also reduced soluble protease activity in vitro indicating that down-regulation of membrane aminopeptidases was not due to their proteolytic clip. No modulation in the activity of any of the enzymes tested was seen with human recombinant tumor necrosis factor-alpha or retinol which do not induce HL-60 cell differentiation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8398990     DOI: 10.1093/intimm/5.8.965

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  6 in total

Review 1.  The rise and fall of central dogmas.

Authors:  George Klein; Eva Klein
Journal:  Oncoimmunology       Date:  2016-09-26       Impact factor: 8.110

2.  Changes in monocytic expression of aminopeptidase N/CD13 after major trauma.

Authors:  G Huschak; K Zur Nieden; R Stuttmann; D Riemann
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

3.  Colony growth of human hematopoietic progenitor cells in the absence of serum is supported by a proteinase inhibitor identified as antileukoproteinase.

Authors:  H M Goselink; J van Damme; P S Hiemstra; A Wuyts; J Stolk; W E Fibbe; R Willemze; J H Falkenburg
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

Review 4.  CD13--not just a marker in leukemia typing.

Authors:  D Riemann; A Kehlen; J Langner
Journal:  Immunol Today       Date:  1999-02

5.  Regulation of aminopeptidase N (EC 3.4.11.2; APN; CD13) by interferon-gamma on the HL-60 cell line.

Authors:  Jelka Gabrilovac; Davorka Breljak; Barbara Cupić; Andreja Ambriović-Ristov
Journal:  Life Sci       Date:  2005-04-22       Impact factor: 5.037

Review 6.  The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis.

Authors:  Yannick Waumans; Lesley Baerts; Kaat Kehoe; Anne-Marie Lambeir; Ingrid De Meester
Journal:  Front Immunol       Date:  2015-08-07       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.